Potentially Inappropriate Prescriptions in Ambulatory Elderly Patients Living in Rural Areas of Romania Using STOPP/START (Version 2) Criteria.
Aged
Aged, 80 and over
Cross-Sectional Studies
Drug-Related Side Effects and Adverse Reactions
Female
General Practitioners
Humans
Inappropriate Prescribing
/ prevention & control
Male
Mass Screening
Medication Errors
/ prevention & control
Potentially Inappropriate Medication List
/ statistics & numerical data
Practice Patterns, Physicians'
/ statistics & numerical data
Prevalence
Primary Health Care
/ standards
Romania
Romanian elderly
START
STOPP
chronic prescriptions
rural zones
Journal
Clinical interventions in aging
ISSN: 1178-1998
Titre abrégé: Clin Interv Aging
Pays: New Zealand
ID NLM: 101273480
Informations de publication
Date de publication:
2020
2020
Historique:
received:
03
10
2019
accepted:
29
01
2020
entrez:
8
4
2020
pubmed:
8
4
2020
medline:
17
9
2020
Statut:
epublish
Résumé
Rational use of medications and monitoring of prescriptions in elderly patients is important to decrease the number and duration of hospitalizations, emergency medical consultations, mortality, as well as medical costs. To identify potentially inappropriate medications (PIMs) and potential prescription omissions (PPOs), and determine their prevalence based on the Screening Tool of Older Persons' potentially inappropriate Prescriptions (STOPP) v2 criteria and Screening Tool to Alert doctors to Right Treatment (START) v2 criteria for patients aged >65 years. This cross-sectional study was conducted in two rural counties in Romania based on electronic prescriptions for chronic conditions (EPCCs) issued from 30 days to 90 days by a specialist or general practitioner. Collected EPCCs were evaluated by an interdisciplinary team of specialists based on 26 STOPP v2 criteria and 10 START v2 criteria. PIM prevalence was 25.80% and PPO prevalence was 41.72% for 646 EPCCs. The mean age of patients was 75 years and the mean number of drugs per EPCC was four. The most frequently identified PIMs were treatment duration (6.65%), theophylline administration (5.72%), drug indication (4.64%), cyclo-oxygenase-2 non-steroidal anti-inflammatory drugs (1.39%), and zopiclone prescription (0.77%). Statins (24.76%), beta-blockers (8.04%), and beta-2 agonist/antimuscarinic bronchodilators (5.88%) were the most frequently identified PPOs. PPOs were more prevalent than PIMs for elderly populations living in the two rural counties in Romania we studied. Health practitioners (family physicians, specialists, and pharmacists) should focus on prophylactic and curative considerations when prescribing agents to decrease the morbidity and mortality of elderly rural Romanian patients.
Sections du résumé
BACKGROUND
BACKGROUND
Rational use of medications and monitoring of prescriptions in elderly patients is important to decrease the number and duration of hospitalizations, emergency medical consultations, mortality, as well as medical costs.
PURPOSE
OBJECTIVE
To identify potentially inappropriate medications (PIMs) and potential prescription omissions (PPOs), and determine their prevalence based on the Screening Tool of Older Persons' potentially inappropriate Prescriptions (STOPP) v2 criteria and Screening Tool to Alert doctors to Right Treatment (START) v2 criteria for patients aged >65 years.
METHODS
METHODS
This cross-sectional study was conducted in two rural counties in Romania based on electronic prescriptions for chronic conditions (EPCCs) issued from 30 days to 90 days by a specialist or general practitioner. Collected EPCCs were evaluated by an interdisciplinary team of specialists based on 26 STOPP v2 criteria and 10 START v2 criteria.
RESULTS
RESULTS
PIM prevalence was 25.80% and PPO prevalence was 41.72% for 646 EPCCs. The mean age of patients was 75 years and the mean number of drugs per EPCC was four. The most frequently identified PIMs were treatment duration (6.65%), theophylline administration (5.72%), drug indication (4.64%), cyclo-oxygenase-2 non-steroidal anti-inflammatory drugs (1.39%), and zopiclone prescription (0.77%). Statins (24.76%), beta-blockers (8.04%), and beta-2 agonist/antimuscarinic bronchodilators (5.88%) were the most frequently identified PPOs.
CONCLUSION
CONCLUSIONS
PPOs were more prevalent than PIMs for elderly populations living in the two rural counties in Romania we studied. Health practitioners (family physicians, specialists, and pharmacists) should focus on prophylactic and curative considerations when prescribing agents to decrease the morbidity and mortality of elderly rural Romanian patients.
Identifiants
pubmed: 32256055
doi: 10.2147/CIA.S233270
pii: 233270
pmc: PMC7090181
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
407-417Informations de copyright
© 2020 Buda et al.
Déclaration de conflit d'intérêts
Dr Liana Dehelean reports personal fees from Johnson and Johnson, Lundbeck, Eli Lilly and Angelini, outside of the submitted work. The authors report no other conflicts of interest in this work.
Références
Geriatr Gerontol Int. 2017 Dec;17(12):2520-2526
pubmed: 28858424
Aging Clin Exp Res. 2016 Aug;28(4):761-8
pubmed: 26661647
Br J Gen Pract. 2017 Sep;67(662):e609-e613
pubmed: 28716996
BMC Pharmacol Toxicol. 2016 Aug 21;17(1):38
pubmed: 27544266
Br J Clin Pharmacol. 2016 Nov;82(5):1382-1392
pubmed: 27426227
Eur J Clin Pharmacol. 2015 Apr;71(4):473-82
pubmed: 25666030
Semergen. 2019 Apr;45(3):180-186
pubmed: 30545673
Integr Pharm Res Pract. 2017 Jan 25;6:37-46
pubmed: 29354549
J Formos Med Assoc. 2018 Mar;117(3):235-243
pubmed: 28549592
PLoS One. 2014 Apr 24;9(4):e95536
pubmed: 24763332
Drugs Aging. 2013 Nov;30(11):935-43
pubmed: 24002743
Eur J Prev Cardiol. 2019 May 14;:2047487319848105
pubmed: 31088130
Br J Clin Pharmacol. 2016 Sep;82(3):849-57
pubmed: 27136457
Clin Interv Aging. 2016 Sep 26;11:1343-1350
pubmed: 27713625
J Public Health (Oxf). 2016 Jun;38(2):e158-70
pubmed: 26175537
Health Serv Res. 2017 Aug;52(4):1534-1549
pubmed: 27686781
BMJ Open. 2015 Nov 25;5(11):e010146
pubmed: 26608642
J Am Geriatr Soc. 2016 Oct;64(10):2116-2121
pubmed: 27590566
Chin Med J (Engl). 2016 Jan 5;129(1):22-7
pubmed: 26712428
Int J Clin Pharm. 2013 Apr;35(2):230-5
pubmed: 23225094
Age Ageing. 2015 Mar;44(2):213-8
pubmed: 25324330
BMJ Open. 2018 Mar 22;8(3):e019003
pubmed: 29567842
Drugs Aging. 2012 Mar 1;29(3):225-232
pubmed: 22372725
Eur J Clin Pharmacol. 2015 Dec;71(12):1415-27
pubmed: 26407687
Farm Hosp. 2015 Jul 01;39(4):192-202
pubmed: 26276737
Aging Dis. 2018 Feb 1;9(1):143-150
pubmed: 29392089
Neuropsychiatr Dis Treat. 2019 Jan 25;15:349-355
pubmed: 30774346
Aging Clin Exp Res. 2019 Aug 19;:
pubmed: 31429004
Br J Clin Pharmacol. 2009 Dec;68(6):936-47
pubmed: 20002089
Clin Interv Aging. 2016 Jun 20;11:819-27
pubmed: 27382265